Gene Query: DPH7

Dataset Description Geneva Score
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 20.2
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 15.06
Transcriptome-wide identification of CELF2 functional targets in T cells 10.91
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 10.76
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 9.18
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 8.79
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 8.59
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.46
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 7.37
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 7.31
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 7.19
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.91
Gene expression signatures of innate lymphoid cells from human blood 6.76
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 6.39
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.02
Neonatal and adult human testis defined at the single-cell level 5.91
Modulation of nonsense-mediated decay by rapamycin 5.75
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 5.73
Gene expression analysis upon mtDNA depletion 5.56
Gene expression analysis upon mtDNA depletion [RNA-seq] 5.56
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 5.39
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 5.39
PRDM1 inhibits proliferation of human colon cancer organoids 5.18
METTL3 promotes translation in human cancer cells 5.16
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 5.16
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 5.08
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 5.07
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 5.04
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 5.01
ENCODE Cold Spring Harbor Labs Long RNA-seq 4.96
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 4.91
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 4.9
4sUDRB-seq: measuring transcription elongation and initiation genomewide 4.86
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 4.75
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.74
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.74
Gene expression in GBM with Cav3.2 inhibition 4.74
Chromatin-informed inference of transcriptional programs in gynecologic cancers 4.71
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 4.71
U1 snRNP telescripting regulates size-function stratified human genome 4.7
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 4.67
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 4.62
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 4.61
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 4.61
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 4.48
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 4.48
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 4.44
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.38
Capturing the Interactome of Newly Transcribed RNA 4.38
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.33
Paxillin regulates genomic networks in prostate cancer [PC3] 4.31
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.26
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.23
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.15
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 4.1
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.1
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 4.09
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 4.08
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 4.04
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.99
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 3.95
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.9
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.86
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 3.66
RNA sequencing of GlyH-101-treated MCF-7 cell line 3.58
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 3.49
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 3.49
Cajal bodies are linked to genome conformation [RNA-Seq] 3.46
Cajal bodies are linked to genome conformation 3.46
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 3.46
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 3.46
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 3.45
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 3.43
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 3.41
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 3.4
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 3.4
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.34
mRNA expression profile of Lymphocytes by high-throuput sequencing 3.34
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.32
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 3.31
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.28
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 3.28
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.25
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.25
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.25
Transcriptional profiling of microglia; current state of the art and future perspectives 3.24
Characterization of human ILC2 subsets 3.24
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.21
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 3.21
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 3.21
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 3.17
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 3.16
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.14
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.14
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 3.14
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.13
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 3.11
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 3.11
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.1
Energy Metabolism during Anchorage-Independence 3.1
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 3.09
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 3.09
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.08
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.08
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.08
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.99
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 2.97
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.96
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.96
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 2.95
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 2.95
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.95
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.95
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.94
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.9
The Human Testis Cell Atlas via Single-cell RNA-seq 2.9
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.88
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 2.85
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 2.84
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.83
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.81
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.8
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.79
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.79
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.79
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 2.79
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 2.78
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 2.78
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 2.76
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 2.76
RNA-seq of cells with TET1 knockout 2.75
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 2.74
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 2.73
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 2.72
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.7
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.64
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.64
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.61
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.61
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 2.6
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 2.58
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.58
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.58
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.58
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.58
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.58
Global Mapping of Human RNA-RNA Interactions 2.55
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.54
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 2.5
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 2.47
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 2.47
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 2.47
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 2.47
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 2.45
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 2.43
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 2.43
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 2.42
Differetially expressed genes after hTR overexpression in U2OS cells 2.42
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 2.41
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.41
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.41
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.41
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 2.4
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 2.39
MeRIP-seq for heat shock in B-cell lymphoma cells 2.39
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.38
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.37
Seletive inhibition of CDK9 in DLBCL cell lines 2.37
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 2.35
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.35
PTHrP overexpression in MCF7 cells 2.34
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 2.33
RNAseq Study in CC-671 Treated Cal-51 Cells 2.32
Global analysis of alternative splicing regulated by RBM10 2.3
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 2.3
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 2.3
Transcriptomes in healthy and CHB fetal hearts 2.3
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.29
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 2.29
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.28
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 2.26
Mapping interactions for the TNIP2 hub protein 2.25
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 2.24
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 2.24
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.24
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.22
RNA-seq analysis of AML cells in response to ASLAN003 2.22
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 2.21
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.2
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 2.2
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.19
A transcriptome-wide divergence in protein translation scales with LIN28B expression 2.18
Global response to chemotherapy-induced apoptosis 2.15
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.14
Next Generation Sequencing of human SMA and healthy control Motor Neurons 2.14
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 2.14
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.14
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.14
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 2.13
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.13
The MEF2B Regulatory Network - RNA-seq data 2.11
The MEF2B Regulatory Network 2.11
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 2.1
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.09
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 2.08
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.08
Uridylation by TUT4 and TUT7 marks mRNA for degradation 2.08
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 2.08
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 2.06
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.04
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 2.04
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.02
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.01
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.01
Paxillin regulates genomic networks in prostate cancer [LNCaP] 1.97
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.96
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 1.95
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 1.95
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 1.94
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.94
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 1.94
Recovery and analysis of nascent RNA 1.91
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 1.91
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.91
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.85
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 1.84
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 1.84
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.83
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.82
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 1.79
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.79
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.76
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.76
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 1.72
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.7
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.7
UV_24h_GRO-Seq 1.68
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 1.68
Controlling for gene expression changes in transcription factor protein networks. 1.68
METTL3 and WTAP 1.67
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.67
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.67
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.66
Transciptomic profiling of human fetal lung samples 1.66
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.66
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.65
N6-methyladenine DNA Modification in Glioblastoma 1.64
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.64
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 1.63
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 1.63
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.62
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.62
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 1.61
Effect of drugs on transcriptomic profiles 1.59
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.58
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.58
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.58
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.58
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.57
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.55
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.54
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.5
Single-cell analysis of adult human ovary using 10X genomics 1.49
Targeted enhancer activation by a subunit of the integrator complex 1.48
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.48
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.45
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.44
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.44
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.44
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.41
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.41
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.41
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.4
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.39
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.38
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.38
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.36
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 1.36
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.36
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.36
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 1.35
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.33
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.32
Dysregulated immune system networks in war veterans with PTSD 1.31
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 1.31
miRNAs affected by antagomiR-17 treatment 1.3
Knockdown of ADNP in HCT116 colon cancer cells 1.27
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.27
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.27
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.26
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.26
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.26
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.25
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.25
SRSF1 role in cellular gene expression and splicing 1.24
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.23
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 1.23
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.22
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.22
Determining mRNA half-lives on a transcriptome-wide scale 1.2
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.18
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.17
RNA-seq analysis upon ARID1B overexpression 1.15
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.15
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.14
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.13
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 1.1
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.08
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 1.07
Ribosome profiling upon inhibition of eIF4A 1.07
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 1.07
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.06
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 1.04
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.04
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.03
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.03
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.02
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.02
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.02
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.0
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.0
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.0
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.0
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.99
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 0.99
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.98
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.98
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.96
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.95
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.93
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.93
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.93
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.92
Illumina Total RNA-seq in HeLa 0.92
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 0.91
Active translatome profiling with RiboLace in MCF7 cells 0.91
BASP1 modifies the Tamoxifen response 0.91
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.9
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.9
Stem and effector CD8 T-cells from human cancers 0.88
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 0.88
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.87
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.87
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.85
Functional significance of the HIV-1 Tat signature amino acid residues 0.85
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.83
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.83
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.82
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.82
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.81
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.8
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.8
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.8
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.8
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.8
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.78
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.77
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.77
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.76
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.76
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.76
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.74
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.73
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.73
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.72
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.72
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.71
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.7
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.68
Discovering human diabetes-risk gene function with genetics and physiological assays 0.67
quanTIseq: quantifying immune contexture of human tumors 0.67
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.67
Investigate A2M treatment on human prostate cancer and mouse liver 0.66
Investigate A2M treatment on human prostate cancer xenograft in mice 0.66
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.65
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.64
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.63
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 0.63
Gene expression analysis in response to hypoxic pathway inhibition 0.63
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.62
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.62
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.62
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.61
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.61
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.61
Gene expression analysis of breast cancer cell-lines 0.6
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.6
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.6
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.57
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.56
Transcriptome of activated human and mouse MAIT cells 0.56
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.55
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.55
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.55
KLF6-dependent transcription in renal cancer cells 0.53
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.53
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.53
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.51
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.51
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.5
The DPYSL2 gene connects mTOR and schizophrenia 0.5
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.49
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.48
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.48
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.48
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.48
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.47
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.47
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.46
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.46
H1609088 Human RNA-Sequencing 0.45
Induced DNA demethylation, genome instability and transcription 0.45
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.45
RNA-seq of SCLC PDX models treated with EP 0.44
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.43
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.43
Analyses of T-ALL (COG study) 0.43
RNA sequencing of T-ALL (COG study) 0.43
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 0.42
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 0.42
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.42
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.41
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.41
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.41
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.41
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 0.4
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.39
K562 polyA RNA-Seq 0.39
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.38
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.37
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.37
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.36
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.36
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.35
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.35
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.32
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.31
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.3
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.3
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.3
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.29
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.29
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.29
mRNA recovered upon RNF219 IP. [RNA-IP] 0.28
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.28
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.28
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.27
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.27
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.24
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.23
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.23
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.21
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.2
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.2
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.19
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 0.19
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.18
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.17
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.17
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.17
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.16
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.16
An optimization system for isolating and sequencing of single human colon cancer cells 0.16
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.15
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.15
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.15
Copper Regulation of HIF-1 Transcription Activity 0.12
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.12
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.12
Epigenomic conservation of transposable element silencing [RNA-seq] 0.11
Epigenomic conservation of transposable element silencing 0.11
RNA-seq differential expression studies: more sequence, or more replication? 0.11
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.1
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.1
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.1
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.09
iPSC derived motor neuron cultures from C9ORF72 carriers 0.08
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.08
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.07
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.07
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.07
Downregulation of LATS kinases alters p53 to promote cell migration 0.07
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.07
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.07
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.05
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.05
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.05
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.04
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.04
FOXP2's impact on the primate transcriptome 0.04
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.04
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.04
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.03
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.03
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.03
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.03
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.01
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.01
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.01
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation